Cristiana M Toscano

Summary

Country: Brazil

Publications

  1. doi request reprint Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience
    C M Toscano
    Department of Community Health, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, Goias, Brazil
    Vaccine 31:C12-8. 2013
  2. doi request reprint Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica
    C M Toscano
    Department of Community Health, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, Goias, Brazil
    Vaccine 31:C88-93. 2013
  3. pmc Cost effectiveness of OptiMal® rapid diagnostic test for malaria in remote areas of the Amazon Region, Brazil
    Maria Regina Fernandes de Oliveira
    School of Medicine, University of Brasilia, Brasilia, Brazil
    Malar J 9:277. 2010
  4. pmc Initial impact and cost of a nationwide population screening campaign for diabetes in Brazil: a follow up study
    Cristiana M Toscano
    Graduate Studies Program in Epidemiology, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
    BMC Health Serv Res 8:189. 2008
  5. doi request reprint Gram-negative bloodstream infections in hematopoietic stem cell transplant patients: the roles of needleless device use, bathing practices, and catheter care
    Cristiana M Toscano
    World Health Organization, 20 Ave Appia, Geneva, Switzerland
    Am J Infect Control 37:327-34. 2009
  6. ncbi request reprint [Economic analysis of a screening program for diabetes mellitus in Brazil]
    Alvaro E Georg
    Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil
    Rev Saude Publica 39:452-60. 2005
  7. ncbi request reprint A nationwide population screening program for diabetes in Brazil
    Luciana B Nucci
    Federal University of Rio Grande do Sul, School of Medicine, Graduate Studies Program in Epidemiology, Porto Alegre, Rio Grande do Sul, Brazil
    Rev Panam Salud Publica 16:320-7. 2004
  8. doi request reprint Pneumococcal disease manifestation in children before and after vaccination: what's new?
    Ana Lucia Andrade
    Department of Community Health, Institute of Tropical Pathology and Public Health, Federal University of Goias, Rua 235, esq 1a Avenida, Setor Leste Universitário, 74605 050 Goiânia, Goias, Brazil
    Vaccine 29:C2-14. 2011

Collaborators

Detail Information

Publications8

  1. doi request reprint Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience
    C M Toscano
    Department of Community Health, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, Goias, Brazil
    Vaccine 31:C12-8. 2013
    ..We describe the process of establishing the ProVac Network of CoEs and its initial outcomes and challenges...
  2. doi request reprint Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica
    C M Toscano
    Department of Community Health, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, Goias, Brazil
    Vaccine 31:C88-93. 2013
    ..As surveillance for diseases prevented by new vaccines is integrated into existing surveillance systems, these systems could cost more than routine surveillance for VPDs targeted by the Expanded Program on Immunization...
  3. pmc Cost effectiveness of OptiMal® rapid diagnostic test for malaria in remote areas of the Amazon Region, Brazil
    Maria Regina Fernandes de Oliveira
    School of Medicine, University of Brasilia, Brasilia, Brazil
    Malar J 9:277. 2010
    ..In areas with limited structure in place for microscopy diagnosis, rapid diagnostic tests (RDT) have been demonstrated to be effective...
  4. pmc Initial impact and cost of a nationwide population screening campaign for diabetes in Brazil: a follow up study
    Cristiana M Toscano
    Graduate Studies Program in Epidemiology, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
    BMC Health Serv Res 8:189. 2008
    ..The objective of this study is to evaluate the initial impact of the program...
  5. doi request reprint Gram-negative bloodstream infections in hematopoietic stem cell transplant patients: the roles of needleless device use, bathing practices, and catheter care
    Cristiana M Toscano
    World Health Organization, 20 Ave Appia, Geneva, Switzerland
    Am J Infect Control 37:327-34. 2009
    ..The objectives of the present study were to determine strategies for controlling the outbreak and identify risk factors for GN-BSI...
  6. ncbi request reprint [Economic analysis of a screening program for diabetes mellitus in Brazil]
    Alvaro E Georg
    Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil
    Rev Saude Publica 39:452-60. 2005
    ..In 2001, the Brazilian Ministry of Health conducted a national diabetes screening campaign. The purpose of this study was to estimate the yield and economic impact of this screening strategy...
  7. ncbi request reprint A nationwide population screening program for diabetes in Brazil
    Luciana B Nucci
    Federal University of Rio Grande do Sul, School of Medicine, Graduate Studies Program in Epidemiology, Porto Alegre, Rio Grande do Sul, Brazil
    Rev Panam Salud Publica 16:320-7. 2004
    ..This report describes the overall participation rate and positivity rate of the screening campaign, as well as factors associated with the level of participation among the municipalities in Brazil...
  8. doi request reprint Pneumococcal disease manifestation in children before and after vaccination: what's new?
    Ana Lucia Andrade
    Department of Community Health, Institute of Tropical Pathology and Public Health, Federal University of Goias, Rua 235, esq 1a Avenida, Setor Leste Universitário, 74605 050 Goiânia, Goias, Brazil
    Vaccine 29:C2-14. 2011
    ..The extension of serotype coverage with the new conjugate vaccines is promising for pneumococcal infections and coverage against antibiotic-resistant strains...